Efavirenz/emtricitabine/tenofovir disoproxil vs Oseltamivir phosphate
Oseltamivir phosphate was dispensed 336.0× as often as Efavirenz/emtricitabine/tenofovir disoproxil in September 2025 — 336 items versus 1 in England.
Efavirenz/emtricitabine/tenofovir disoproxil · September 2025
NHSBSA Prescription Cost Analysis
Oseltamivir phosphate · September 2025
NHSBSA Prescription Cost Analysis
Figure 1. Efavirenz/emtricitabine/tenofovir disoproxil versus Oseltamivir phosphate: national items dispensed by month
▬ Efavirenz/emtricitabine/tenofovir disoproxil · ╌ Oseltamivir phosphate
Source: NHSBSA Prescription Cost Analysis, to September 2025
| Measure | Efavirenz/emtricitabine/tenofovir disoproxil | Oseltamivir phosphate |
|---|---|---|
| Items, September 2025 | 1 | 336 |
| Items, last 12 months | 12 | 37,292 |
| Net ingredient cost, September 2025 | £533 | £5,074 |
See the full profile for Efavirenz/emtricitabine/tenofovir disoproxil or Oseltamivir phosphate.